
     <p><b>American Innovation and R&amp;D Competitiveness Act of 2021</b></p> <p>This bill eliminates the five-year amortization requirement for research and experimental expenditures scheduled to begin in 2022, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred. </p>
    